| |
A
European network, including
22 Universities and research
institutions, is being established
in this project. Their goals
is to develop new active substances
against HIV, in particular those
inhibiting the replication of
the virus. These anti HIV-1
reverse transcriptase inhibitors
should specifically have an
effect against multi-resistance
HIV strains. They are primarily
based on oligo- ribonucleic
acids, such as aptamers and
siRNAs. Prof. Dr. Joachim Engels
and “Georg-Speyer-Haus”
scientists are participating
in this project. |
